166 related articles for article (PubMed ID: 27206219)
21. Anticancer effect of sirolimus in renal allograft recipients with de novo malignancies.
Boratyńska M; Watorek E; Smolska D; Patrzałek D; Klinger M
Transplant Proc; 2007 Nov; 39(9):2736-9. PubMed ID: 18021973
[TBL] [Abstract][Full Text] [Related]
22. National survey of de novo malignancy after solid organ transplantation in Japan.
Miyazaki T; Sato S; Kondo T; Kusaka M; Gotoh M; Saiki Y; Ono M; Kokudo N; Enosawa S; Satoh S; Soeda E; Furukawa H; Kobayashi E; Nagayasu T
Surg Today; 2018 Jun; 48(6):618-624. PubMed ID: 29380136
[TBL] [Abstract][Full Text] [Related]
23. Post-transplantation Malignancy After Kidney Transplantation in Turkey.
Keles Y; Tekin S; Duzenli M; Yuksel Y; Yücetin L; Dosemeci L; Sengul A; Demirbaş A; Tuncer M
Transplant Proc; 2015 Jun; 47(5):1418-20. PubMed ID: 26093732
[TBL] [Abstract][Full Text] [Related]
24. Immunosuppressive regimen and risk for de novo malignancies after liver transplantation for alcoholic liver disease.
Dumortier J; Maucort-Boulch D; Poinsot D; Thimonier E; Chambon-Augoyard C; Ducroux E; Vallin M; Walter T; Robinson P; Guillaud O; Boillot O
Clin Res Hepatol Gastroenterol; 2018 Oct; 42(5):427-435. PubMed ID: 29861393
[TBL] [Abstract][Full Text] [Related]
25. De novo noncutaneous malignancies after kidney transplantation are associated with an increased risk of graft failure: results from a time-dependent analysis on 672 patients.
Cena T; Musetti C; Quaglia M; Magnani C; Stratta P; Bagnardi V; Cantaluppi V
Transpl Int; 2016 Oct; 29(10):1085-93. PubMed ID: 27343849
[TBL] [Abstract][Full Text] [Related]
26. Chronologically different incidences of post-transplant malignancies in renal transplant recipients: single center experience.
Ju MK; Joo DJ; Kim SJ; Huh KH; Kim MS; Jeon KO; Kim HJ; Kim SI; Kim YS
Transpl Int; 2009 Jun; 22(6):644-53. PubMed ID: 19220824
[TBL] [Abstract][Full Text] [Related]
27. Skin cancer after renal transplantation: Results of a multicenter study in Iran.
Einollahi B; Nemati E; Lessan-Pezeshki M; Simforoosh N; Nourbala MH; Rostami Z; Nafar M; Pourfarziani V; Beiraghdar F; Mahdavi-Mazdeh M; Ahmadpour P; Makhdoomi K; Ghafari A; Ardalan MR; Taebi Khosroshahi H; Oliaei F; Shahidi S; Makhlogh A; Azmandian J; Samimagham HR; Shabazian H
Ann Transplant; 2010; 15(3):44-50. PubMed ID: 20877266
[TBL] [Abstract][Full Text] [Related]
28. De novo malignancies following liver transplantation: a case-control study with long-term follow-up.
Yao FY; Gautam M; Palese C; Rebres R; Terrault N; Roberts JP; Peters MG
Clin Transplant; 2006; 20(5):617-23. PubMed ID: 16968488
[TBL] [Abstract][Full Text] [Related]
29. De novo malignancies after renal transplantation--a single-center experience in the Balkans.
Popov Z; Ivanovski O; Kolevski P; Stankov O; Petrovski D; Cakalaroski K; Ivanovski N
Transplant Proc; 2007 Oct; 39(8):2589-91. PubMed ID: 17954184
[TBL] [Abstract][Full Text] [Related]
30. Malignancies after kidney transplantation.
Rascente M; Pisani F; Barletta A; D'Angelo M; Giammaria A; Parzanese I; Rizza V; Iaria G; Famulari A
Transplant Proc; 2005; 37(6):2529-31. PubMed ID: 16182735
[TBL] [Abstract][Full Text] [Related]
31. Development of urologic de novo malignancies after renal transplantation.
Hevia V; Gómez V; Díez Nicolás V; Alvarez S; Gómez Del Cañizo C; Galeano C; Gomis A; García-Sagredo JM; Marcen R; Burgos FJ
Transplant Proc; 2014; 46(1):170-5. PubMed ID: 24507046
[TBL] [Abstract][Full Text] [Related]
32. Noncutaneous neoplasms after kidney transplantation: analysis at single center.
Rocha A; Malheiro J; Fonseca I; Martins LS; Dias L; Almeida M; Pedroso S; Henriques AC
Transplant Proc; 2013 Apr; 45(3):1102-5. PubMed ID: 23622637
[TBL] [Abstract][Full Text] [Related]
33. Incidence, risk factors and outcomes of malignancies after kidney transplantation in Singapore: a 12-year experience.
Teo SH; Lee KG; Lim GH; Koo SX; Ramirez ME; Chow KY; Kee T
Singapore Med J; 2019 May; 60(5):253-259. PubMed ID: 30311626
[TBL] [Abstract][Full Text] [Related]
34. De Novo Malignancies After Liver Transplantation With 14 Cases at a Single Center.
Liu ZN; Wang WT; Yan LN;
Transplant Proc; 2015 Oct; 47(8):2483-7. PubMed ID: 26518956
[TBL] [Abstract][Full Text] [Related]
35. Burden of de novo malignancy in the liver transplant recipient.
Chandok N; Watt KD
Liver Transpl; 2012 Nov; 18(11):1277-89. PubMed ID: 22887956
[TBL] [Abstract][Full Text] [Related]
36. The janus face of immunosuppression - de novo malignancy after renal transplantation: the experience of the Transplantation Center Munich.
Wimmer CD; Rentsch M; Crispin A; Illner WD; Arbogast H; Graeb C; Jauch KW; Guba M
Kidney Int; 2007 Jun; 71(12):1271-8. PubMed ID: 17332737
[TBL] [Abstract][Full Text] [Related]
37. Malignancies after renal transplantation in southern Taiwan: experience in one centre.
Feng WW; Wang TN; Chen HC; Ho JC; Ko YC
BJU Int; 2007 Apr; 99(4):825-9. PubMed ID: 17155978
[TBL] [Abstract][Full Text] [Related]
38. Lower malignancy rates in renal allograft recipients converted to sirolimus-based, calcineurin inhibitor-free immunotherapy: 24-month results from the CONVERT trial.
Alberú J; Pascoe MD; Campistol JM; Schena FP; Rial Mdel C; Polinsky M; Neylan JF; Korth-Bradley J; Goldberg-Alberts R; Maller ES;
Transplantation; 2011 Aug; 92(3):303-10. PubMed ID: 21792049
[TBL] [Abstract][Full Text] [Related]
39. Incidence and clinical predictors of a subsequent nonmelanoma skin cancer in solid organ transplant recipients with a first nonmelanoma skin cancer: a multicenter cohort study.
Tessari G; Naldi L; Boschiero L; Nacchia F; Fior F; Forni A; Rugiu C; Faggian G; Sassi F; Gotti E; Fiocchi R; Talamini G; Girolomoni G
Arch Dermatol; 2010 Mar; 146(3):294-9. PubMed ID: 20231501
[TBL] [Abstract][Full Text] [Related]
40. Urologic de novo malignancies after kidney transplantation: a single center experience.
Karczewski M; Czapiewski W; Karczewski J
Transplant Proc; 2012 Jun; 44(5):1293-7. PubMed ID: 22664003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
